{"corpus_id":27916937,"paper_sha":"bf4267fed085a3a563166a0650fe3c55848ca7d5","doi":"10.1111/liv.12903","arxiv_id":null,"pmid":26123841,"pmcid":null,"mag_id":1862643070,"dblp_id":null,"acl_id":null,"title":"Hyperinsulinaemia and insulin signalling in the pathogenesis and the clinical course of hepatocellular carcinoma","year":2015,"publication_date":"2015-10-01","venue":"Liver international (Print)","journal":{"name":"Liver International","pages":"2203 - 2217","volume":"35"},"journal_issn":null,"journal_title":null,"publication_types":["Review","JournalArticle"],"pubmed_pub_types":["Journal Article","Research Support, Non-U.S. Gov't","Review"],"s2_fields_of_study":["Biology","Medicine"],"reference_count":158,"citation_count":104,"influential_citation_count":4,"is_open_access":true,"arxiv_categories":null,"arxiv_license":null,"arxiv_journal_ref":null,"mesh_headings":[{"d":"Animals","mj":false,"ui":"D000818"},{"d":"Carcinoma, Hepatocellular","mj":false,"qs":[{"q":"metabolism","mj":true,"ui":"Q000378"},{"q":"pathology","mj":false,"ui":"Q000473"}],"ui":"D006528"},{"d":"Diabetes Mellitus, Type 2","mj":false,"qs":[{"q":"complications","mj":false,"ui":"Q000150"}],"ui":"D003924"},{"d":"Disease Models, Animal","mj":false,"ui":"D004195"},{"d":"Disease Progression","mj":false,"ui":"D018450"},{"d":"Hepatitis C","mj":false,"qs":[{"q":"complications","mj":false,"ui":"Q000150"}],"ui":"D006526"},{"d":"Humans","mj":false,"ui":"D006801"},{"d":"Hyperinsulinism","mj":false,"qs":[{"q":"metabolism","mj":true,"ui":"Q000378"},{"q":"pathology","mj":false,"ui":"Q000473"}],"ui":"D006946"},{"d":"Insulin","mj":false,"qs":[{"q":"physiology","mj":false,"ui":"Q000502"}],"ui":"D007328"},{"d":"Insulin Resistance","mj":true,"ui":"D007333"},{"d":"Liver Cirrhosis","mj":false,"qs":[{"q":"complications","mj":false,"ui":"Q000150"}],"ui":"D008103"},{"d":"Liver Neoplasms","mj":false,"qs":[{"q":"metabolism","mj":true,"ui":"Q000378"},{"q":"pathology","mj":false,"ui":"Q000473"}],"ui":"D008113"},{"d":"Metabolic Syndrome","mj":false,"qs":[{"q":"complications","mj":false,"ui":"Q000150"}],"ui":"D024821"},{"d":"Mice","mj":false,"ui":"D051379"},{"d":"Non-alcoholic Fatty Liver Disease","mj":false,"qs":[{"q":"complications","mj":false,"ui":"Q000150"}],"ui":"D065626"},{"d":"Obesity","mj":false,"qs":[{"q":"complications","mj":false,"ui":"Q000150"}],"ui":"D009765"},{"d":"Rats","mj":false,"ui":"D051381"},{"d":"Risk Factors","mj":false,"ui":"D012307"},{"d":"Signal Transduction","mj":true,"ui":"D015398"}],"chemicals":[{"n":"Insulin","ui":"D007328","reg":"0"}],"comments_corrections":null,"source_flags":5,"s2_open_access_pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/liv.12903","s2_open_access_landing_url":"https://www.semanticscholar.org/paper/bf4267fed085a3a563166a0650fe3c55848ca7d5","s2_open_access_license":"CCBY","s2_open_access_status":"HYBRID","pmc_open_access_pdf_url":null,"pmc_open_access_landing_url":null,"pmc_open_access_license":null,"pmc_open_access_status":null,"unpaywall_open_access_pdf_url":null,"unpaywall_open_access_landing_url":null,"unpaywall_open_access_license":null,"unpaywall_open_access_status":null,"abstract":"Hepatocellular carcinoma (HCC) is the fifth most prevalent cancer and is one of the leading causes of cancer‐related death. The risk factors for HCC include cirrhosis, chronic viral hepatitis, heavy alcohol intake and metabolic diseases such as obesity, type 2 diabetes and metabolic syndrome. Insulin resistance is a common denominator of all of these conditions and is tethered to hyperinsulinaemia. Here, we give an overview of the recent advances linking hyperinsulinaemia to HCC development and progression. In particular, we summarise the underlying causes of hyperinsulinaemia in the setting of chronic liver diseases. We present epidemiological evidence linking metabolic diseases to HCC risk and HCC‐related mortality, as well as the pathogenic cellular and molecular mechanisms explaining this relation. A better understanding of the mechanisms by which insulin participates in HCC biology might ultimately provide novel opportunities for prevention and treatment.","claims":[{"public_id":"cl_d7e0e2069e2628369db9f58a8aae248e","status":"active","text":"Hyperinsulinaemia is linked to hepatocellular carcinoma development and progression.","confidence":0.96,"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/claims/cl_d7e0e2069e2628369db9f58a8aae248e"},{"public_id":"cl_252490970cd5c68135a82c6b1b679a6b","status":"active","text":"Insulin participates in hepatocellular carcinoma biology in ways that may offer novel opportunities for prevention and treatment.","confidence":0.78,"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/claims/cl_252490970cd5c68135a82c6b1b679a6b"},{"public_id":"cl_751cca6e5975434361d35e2c9cc17150","status":"active","text":"Metabolic diseases are associated with increased hepatocellular carcinoma risk and hepatocellular carcinoma-related mortality.","confidence":0.92,"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/claims/cl_751cca6e5975434361d35e2c9cc17150"},{"public_id":"cl_55d68ce3fe521334b54ff4f0739520fb","status":"active","text":"Pathogenic cellular and molecular mechanisms are presented to explain the association between metabolic diseases and hepatocellular carcinoma.","confidence":0.85,"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/claims/cl_55d68ce3fe521334b54ff4f0739520fb"}],"concepts":[{"public_id":"co_07ecf38dd8f07345b549e5d1195d1371","status":"active","name":"insulin signalling","description":"The signaling pathways activated by insulin that influence cellular behavior.","types":["signaling pathway"],"aliases":["insulin signaling"],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_07ecf38dd8f07345b549e5d1195d1371"},{"public_id":"co_113b25e5782e41173608c5f8c6acccd8","status":"active","name":"HCC-related mortality","description":"Death attributable to hepatocellular carcinoma.","types":["outcome"],"aliases":["hepatocellular carcinoma-related mortality"],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_113b25e5782e41173608c5f8c6acccd8"},{"public_id":"co_2789547ef39b47e442f4376705cf9954","status":"active","name":"metabolic diseases","description":"Metabolic conditions discussed as HCC risk factors, including obesity, type 2 diabetes, and metabolic syndrome.","types":["disease group"],"aliases":[],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_2789547ef39b47e442f4376705cf9954"},{"public_id":"co_2dfcaa19cf00cee3207d849963a2deb9","status":"active","name":"pathogenic cellular and molecular mechanisms","description":"Cellular and molecular processes proposed to explain how metabolic disease relates to hepatocellular carcinoma.","types":["mechanism"],"aliases":[],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_2dfcaa19cf00cee3207d849963a2deb9"},{"public_id":"co_32602b13e0b335638e26d709d91fcabd","status":"active","name":"development and progression","description":"The emergence and worsening of hepatocellular carcinoma.","types":["disease course"],"aliases":[],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_32602b13e0b335638e26d709d91fcabd"},{"public_id":"co_c2a3589b5c80a2b42d0a7a55ed23ecba","status":"active","name":"prevention and treatment","description":"Potential clinical strategies for reducing hepatocellular carcinoma risk or managing the disease.","types":["clinical application"],"aliases":[],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_c2a3589b5c80a2b42d0a7a55ed23ecba"},{"public_id":"co_daf0179faa601e0a570011484122b294","status":"active","name":"hyperinsulinaemia","description":"Elevated circulating insulin levels.","types":["biological state"],"aliases":["hyperinsulinemia"],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_daf0179faa601e0a570011484122b294"},{"public_id":"co_ed10db0eec74e813b0be684936fb89bb","status":"active","name":"hepatocellular carcinoma","description":"A primary malignancy of the liver, abbreviated as HCC in the title and abstract.","types":["cancer"],"aliases":["HCC"],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_ed10db0eec74e813b0be684936fb89bb"}],"external_ids":{"DOI":"10.1111/liv.12903","ArXiv":null,"PubMed":26123841,"PubMedCentral":null,"MAG":1862643070,"DBLP":null,"ACL":null},"open_access":{"is_open_access":true,"pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/liv.12903","landing_url":"https://www.semanticscholar.org/paper/bf4267fed085a3a563166a0650fe3c55848ca7d5","source":"semantic_scholar","pdf_url_source":"semantic_scholar_open_access_pdf","license":"CCBY","status":"HYBRID","reason":null},"reference_availability":{"status":"available","references_indexed":true,"full_text_available":false,"full_text_source":null,"count_basis":"semantic_scholar_metadata","extraction_status":"not_applicable","reason":null},"source":{"provider":"episteme2","base_corpus":"semantic_scholar_dump","freshness_mode":"unknown","basis":["semantic_scholar_metadata","postgres_metadata"],"limits":["paper metadata is based on indexed upstream scholarly datasets","claims and concepts are available only for extracted papers","absence of claims or concepts means no extracted graph data is available in this response"],"status":"available","degraded":false,"degraded_reasons":[],"diagnostics":{"status":"available","degraded":false,"degraded_reasons":[],"metadata_status":"available","graph_status":"available","abstract_status":"available"},"source_flags":5},"paper_id":632336,"paper_uid":"aff72141-a476-43c5-bcef-b400205647d6","canonical_identity":{"paper_id":632336,"paper_uid":"aff72141-a476-43c5-bcef-b400205647d6","identity_status":"available","lookup_basis":"semantic_scholar_external_id","compatibility_path":"corpus_id"},"url":"https://sah.borca.ai/papers/27916937"}